Loading…

A fluorescent probe study of plasminogen activator inhibitor-1. Evidence for reactive center loop insertion and its role in the inhibitory mechanism

A mutant recombinant plasminogen activator inhibitor 1 (PAI-1) was created (Ser-338-->Cys) in which cysteine was placed at the P9 position of the reactive center loop. Labeling this mutant with N,N'-dimethyl-N-(acetyl)-N'-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) ethylene diamine (NBD) provid...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of biological chemistry 1995-03, Vol.270 (10), p.5395
Main Authors: Shore, J D, Day, D E, Francis-Chmura, A M, Verhamme, I, Kvassman, J, Lawrence, D A, Ginsburg, D
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 10
container_start_page 5395
container_title The Journal of biological chemistry
container_volume 270
creator Shore, J D
Day, D E
Francis-Chmura, A M
Verhamme, I
Kvassman, J
Lawrence, D A
Ginsburg, D
description A mutant recombinant plasminogen activator inhibitor 1 (PAI-1) was created (Ser-338-->Cys) in which cysteine was placed at the P9 position of the reactive center loop. Labeling this mutant with N,N'-dimethyl-N-(acetyl)-N'-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) ethylene diamine (NBD) provided a molecule with a fluorescent probe at that position. The NBD-labeled mutant was almost as reactive as wild type but was considerably more stable. Complex formation with tissue or urokinase type plasminogen activator (tPA or uPA), and cleavage between P3 and P4 with a catalytic concentration of elastase, all resulted in identical 13-nm blue shifts of the peak fluorescence emission wavelength and 6.2-fold fluorescence enhancements. Formation of latent PAI showed the same 13-nm spectral shift with a 6.7-fold fluorescence emission increase, indicating that the NBD probe is in a slightly more hydrophobic milieu. These changes can be attributed to insertion of the reactive center loop into the beta sheet A of the inhibitor in a manner that exposes the NBD probe to a more hydrophobic milieu. The rate of loop insertion due to tPA complexation was followed using stopped flow fluorimetry. This rate showed a hyperbolic dependence on tPA concentration, with a half-saturation concentration of 0.96 microM and a maximum rate constant of 3.4 s-1. These results demonstrate experimentally that complexation with proteases is presumably associated with loop insertion. The identical fluorescence changes obtained with tPa.PAI-1 and uPA.PAI-1 complexes and elastase-cleaved PAI-1 strongly suggest that in the stable protease-PAI-1 complex the reactive center loop is cleaved and inserted into beta sheet A and that this process is central to the inhibition mechanism.
doi_str_mv 10.1074/jbc.270.10.5395
format article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_7890653</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>7890653</sourcerecordid><originalsourceid>FETCH-LOGICAL-p206t-3bcb6c5bf4681a15113381de474e68ef9b32b008866684f07ff9bbefd9e6d9b43</originalsourceid><addsrcrecordid>eNpFkM1OwzAQhH0AlVI4c0LaF0iwY8dxjlVVfqRKXOBcxc6aukriyHYr9T14YFKoxF52dmb0HZaQB0ZzRivxtNcmL6rzkZe8Lq_InNKCZXVRqhtyG-OeTiNqNiOzStVUlnxOvpdgu4MPGA0OCcbgNUJMh_YE3sLYNbF3g__CARqT3LFJPoAbdk67SWUsh_XRtTgYBDslAX9bCGcYBui8H6d6xJCcnxBDCy5FCL7DyYa0w3_YCXo0u2Zwsb8j17bpIt5f9oJ8Pq8_Vq_Z5v3lbbXcZGNBZcq4NlqaUlshFWtYyRjnirUoKoFSoa01LzSlSkkplbC0spOl0bY1yrbWgi_I4x93POge2-0YXN-E0_byHf4D48ho7g</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>A fluorescent probe study of plasminogen activator inhibitor-1. Evidence for reactive center loop insertion and its role in the inhibitory mechanism</title><source>ScienceDirect Journals</source><creator>Shore, J D ; Day, D E ; Francis-Chmura, A M ; Verhamme, I ; Kvassman, J ; Lawrence, D A ; Ginsburg, D</creator><creatorcontrib>Shore, J D ; Day, D E ; Francis-Chmura, A M ; Verhamme, I ; Kvassman, J ; Lawrence, D A ; Ginsburg, D</creatorcontrib><description>A mutant recombinant plasminogen activator inhibitor 1 (PAI-1) was created (Ser-338--&gt;Cys) in which cysteine was placed at the P9 position of the reactive center loop. Labeling this mutant with N,N'-dimethyl-N-(acetyl)-N'-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) ethylene diamine (NBD) provided a molecule with a fluorescent probe at that position. The NBD-labeled mutant was almost as reactive as wild type but was considerably more stable. Complex formation with tissue or urokinase type plasminogen activator (tPA or uPA), and cleavage between P3 and P4 with a catalytic concentration of elastase, all resulted in identical 13-nm blue shifts of the peak fluorescence emission wavelength and 6.2-fold fluorescence enhancements. Formation of latent PAI showed the same 13-nm spectral shift with a 6.7-fold fluorescence emission increase, indicating that the NBD probe is in a slightly more hydrophobic milieu. These changes can be attributed to insertion of the reactive center loop into the beta sheet A of the inhibitor in a manner that exposes the NBD probe to a more hydrophobic milieu. The rate of loop insertion due to tPA complexation was followed using stopped flow fluorimetry. This rate showed a hyperbolic dependence on tPA concentration, with a half-saturation concentration of 0.96 microM and a maximum rate constant of 3.4 s-1. These results demonstrate experimentally that complexation with proteases is presumably associated with loop insertion. The identical fluorescence changes obtained with tPa.PAI-1 and uPA.PAI-1 complexes and elastase-cleaved PAI-1 strongly suggest that in the stable protease-PAI-1 complex the reactive center loop is cleaved and inserted into beta sheet A and that this process is central to the inhibition mechanism.</description><identifier>ISSN: 0021-9258</identifier><identifier>DOI: 10.1074/jbc.270.10.5395</identifier><identifier>PMID: 7890653</identifier><language>eng</language><publisher>United States</publisher><subject>4-Chloro-7-nitrobenzofurazan ; Amino Acid Sequence ; Base Sequence ; Binding Sites ; Cysteine ; Fluorescent Dyes ; Kinetics ; Molecular Sequence Data ; Mutagenesis, Site-Directed ; Oligodeoxyribonucleotides ; Oxadiazoles ; Plasminogen Activator Inhibitor 1 - chemistry ; Plasminogen Activator Inhibitor 1 - isolation &amp; purification ; Plasminogen Activator Inhibitor 1 - pharmacology ; Point Mutation ; Protein Conformation ; Protein Structure, Secondary ; Recombinant Proteins - chemistry ; Recombinant Proteins - isolation &amp; purification ; Recombinant Proteins - pharmacology ; Serine ; Spectrometry, Fluorescence ; Tissue Plasminogen Activator - antagonists &amp; inhibitors ; Urokinase-Type Plasminogen Activator - antagonists &amp; inhibitors</subject><ispartof>The Journal of biological chemistry, 1995-03, Vol.270 (10), p.5395</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7890653$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shore, J D</creatorcontrib><creatorcontrib>Day, D E</creatorcontrib><creatorcontrib>Francis-Chmura, A M</creatorcontrib><creatorcontrib>Verhamme, I</creatorcontrib><creatorcontrib>Kvassman, J</creatorcontrib><creatorcontrib>Lawrence, D A</creatorcontrib><creatorcontrib>Ginsburg, D</creatorcontrib><title>A fluorescent probe study of plasminogen activator inhibitor-1. Evidence for reactive center loop insertion and its role in the inhibitory mechanism</title><title>The Journal of biological chemistry</title><addtitle>J Biol Chem</addtitle><description>A mutant recombinant plasminogen activator inhibitor 1 (PAI-1) was created (Ser-338--&gt;Cys) in which cysteine was placed at the P9 position of the reactive center loop. Labeling this mutant with N,N'-dimethyl-N-(acetyl)-N'-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) ethylene diamine (NBD) provided a molecule with a fluorescent probe at that position. The NBD-labeled mutant was almost as reactive as wild type but was considerably more stable. Complex formation with tissue or urokinase type plasminogen activator (tPA or uPA), and cleavage between P3 and P4 with a catalytic concentration of elastase, all resulted in identical 13-nm blue shifts of the peak fluorescence emission wavelength and 6.2-fold fluorescence enhancements. Formation of latent PAI showed the same 13-nm spectral shift with a 6.7-fold fluorescence emission increase, indicating that the NBD probe is in a slightly more hydrophobic milieu. These changes can be attributed to insertion of the reactive center loop into the beta sheet A of the inhibitor in a manner that exposes the NBD probe to a more hydrophobic milieu. The rate of loop insertion due to tPA complexation was followed using stopped flow fluorimetry. This rate showed a hyperbolic dependence on tPA concentration, with a half-saturation concentration of 0.96 microM and a maximum rate constant of 3.4 s-1. These results demonstrate experimentally that complexation with proteases is presumably associated with loop insertion. The identical fluorescence changes obtained with tPa.PAI-1 and uPA.PAI-1 complexes and elastase-cleaved PAI-1 strongly suggest that in the stable protease-PAI-1 complex the reactive center loop is cleaved and inserted into beta sheet A and that this process is central to the inhibition mechanism.</description><subject>4-Chloro-7-nitrobenzofurazan</subject><subject>Amino Acid Sequence</subject><subject>Base Sequence</subject><subject>Binding Sites</subject><subject>Cysteine</subject><subject>Fluorescent Dyes</subject><subject>Kinetics</subject><subject>Molecular Sequence Data</subject><subject>Mutagenesis, Site-Directed</subject><subject>Oligodeoxyribonucleotides</subject><subject>Oxadiazoles</subject><subject>Plasminogen Activator Inhibitor 1 - chemistry</subject><subject>Plasminogen Activator Inhibitor 1 - isolation &amp; purification</subject><subject>Plasminogen Activator Inhibitor 1 - pharmacology</subject><subject>Point Mutation</subject><subject>Protein Conformation</subject><subject>Protein Structure, Secondary</subject><subject>Recombinant Proteins - chemistry</subject><subject>Recombinant Proteins - isolation &amp; purification</subject><subject>Recombinant Proteins - pharmacology</subject><subject>Serine</subject><subject>Spectrometry, Fluorescence</subject><subject>Tissue Plasminogen Activator - antagonists &amp; inhibitors</subject><subject>Urokinase-Type Plasminogen Activator - antagonists &amp; inhibitors</subject><issn>0021-9258</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><recordid>eNpFkM1OwzAQhH0AlVI4c0LaF0iwY8dxjlVVfqRKXOBcxc6aukriyHYr9T14YFKoxF52dmb0HZaQB0ZzRivxtNcmL6rzkZe8Lq_InNKCZXVRqhtyG-OeTiNqNiOzStVUlnxOvpdgu4MPGA0OCcbgNUJMh_YE3sLYNbF3g__CARqT3LFJPoAbdk67SWUsh_XRtTgYBDslAX9bCGcYBui8H6d6xJCcnxBDCy5FCL7DyYa0w3_YCXo0u2Zwsb8j17bpIt5f9oJ8Pq8_Vq_Z5v3lbbXcZGNBZcq4NlqaUlshFWtYyRjnirUoKoFSoa01LzSlSkkplbC0spOl0bY1yrbWgi_I4x93POge2-0YXN-E0_byHf4D48ho7g</recordid><startdate>19950310</startdate><enddate>19950310</enddate><creator>Shore, J D</creator><creator>Day, D E</creator><creator>Francis-Chmura, A M</creator><creator>Verhamme, I</creator><creator>Kvassman, J</creator><creator>Lawrence, D A</creator><creator>Ginsburg, D</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>19950310</creationdate><title>A fluorescent probe study of plasminogen activator inhibitor-1. Evidence for reactive center loop insertion and its role in the inhibitory mechanism</title><author>Shore, J D ; Day, D E ; Francis-Chmura, A M ; Verhamme, I ; Kvassman, J ; Lawrence, D A ; Ginsburg, D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p206t-3bcb6c5bf4681a15113381de474e68ef9b32b008866684f07ff9bbefd9e6d9b43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>4-Chloro-7-nitrobenzofurazan</topic><topic>Amino Acid Sequence</topic><topic>Base Sequence</topic><topic>Binding Sites</topic><topic>Cysteine</topic><topic>Fluorescent Dyes</topic><topic>Kinetics</topic><topic>Molecular Sequence Data</topic><topic>Mutagenesis, Site-Directed</topic><topic>Oligodeoxyribonucleotides</topic><topic>Oxadiazoles</topic><topic>Plasminogen Activator Inhibitor 1 - chemistry</topic><topic>Plasminogen Activator Inhibitor 1 - isolation &amp; purification</topic><topic>Plasminogen Activator Inhibitor 1 - pharmacology</topic><topic>Point Mutation</topic><topic>Protein Conformation</topic><topic>Protein Structure, Secondary</topic><topic>Recombinant Proteins - chemistry</topic><topic>Recombinant Proteins - isolation &amp; purification</topic><topic>Recombinant Proteins - pharmacology</topic><topic>Serine</topic><topic>Spectrometry, Fluorescence</topic><topic>Tissue Plasminogen Activator - antagonists &amp; inhibitors</topic><topic>Urokinase-Type Plasminogen Activator - antagonists &amp; inhibitors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shore, J D</creatorcontrib><creatorcontrib>Day, D E</creatorcontrib><creatorcontrib>Francis-Chmura, A M</creatorcontrib><creatorcontrib>Verhamme, I</creatorcontrib><creatorcontrib>Kvassman, J</creatorcontrib><creatorcontrib>Lawrence, D A</creatorcontrib><creatorcontrib>Ginsburg, D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>The Journal of biological chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shore, J D</au><au>Day, D E</au><au>Francis-Chmura, A M</au><au>Verhamme, I</au><au>Kvassman, J</au><au>Lawrence, D A</au><au>Ginsburg, D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A fluorescent probe study of plasminogen activator inhibitor-1. Evidence for reactive center loop insertion and its role in the inhibitory mechanism</atitle><jtitle>The Journal of biological chemistry</jtitle><addtitle>J Biol Chem</addtitle><date>1995-03-10</date><risdate>1995</risdate><volume>270</volume><issue>10</issue><spage>5395</spage><pages>5395-</pages><issn>0021-9258</issn><abstract>A mutant recombinant plasminogen activator inhibitor 1 (PAI-1) was created (Ser-338--&gt;Cys) in which cysteine was placed at the P9 position of the reactive center loop. Labeling this mutant with N,N'-dimethyl-N-(acetyl)-N'-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) ethylene diamine (NBD) provided a molecule with a fluorescent probe at that position. The NBD-labeled mutant was almost as reactive as wild type but was considerably more stable. Complex formation with tissue or urokinase type plasminogen activator (tPA or uPA), and cleavage between P3 and P4 with a catalytic concentration of elastase, all resulted in identical 13-nm blue shifts of the peak fluorescence emission wavelength and 6.2-fold fluorescence enhancements. Formation of latent PAI showed the same 13-nm spectral shift with a 6.7-fold fluorescence emission increase, indicating that the NBD probe is in a slightly more hydrophobic milieu. These changes can be attributed to insertion of the reactive center loop into the beta sheet A of the inhibitor in a manner that exposes the NBD probe to a more hydrophobic milieu. The rate of loop insertion due to tPA complexation was followed using stopped flow fluorimetry. This rate showed a hyperbolic dependence on tPA concentration, with a half-saturation concentration of 0.96 microM and a maximum rate constant of 3.4 s-1. These results demonstrate experimentally that complexation with proteases is presumably associated with loop insertion. The identical fluorescence changes obtained with tPa.PAI-1 and uPA.PAI-1 complexes and elastase-cleaved PAI-1 strongly suggest that in the stable protease-PAI-1 complex the reactive center loop is cleaved and inserted into beta sheet A and that this process is central to the inhibition mechanism.</abstract><cop>United States</cop><pmid>7890653</pmid><doi>10.1074/jbc.270.10.5395</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9258
ispartof The Journal of biological chemistry, 1995-03, Vol.270 (10), p.5395
issn 0021-9258
language eng
recordid cdi_pubmed_primary_7890653
source ScienceDirect Journals
subjects 4-Chloro-7-nitrobenzofurazan
Amino Acid Sequence
Base Sequence
Binding Sites
Cysteine
Fluorescent Dyes
Kinetics
Molecular Sequence Data
Mutagenesis, Site-Directed
Oligodeoxyribonucleotides
Oxadiazoles
Plasminogen Activator Inhibitor 1 - chemistry
Plasminogen Activator Inhibitor 1 - isolation & purification
Plasminogen Activator Inhibitor 1 - pharmacology
Point Mutation
Protein Conformation
Protein Structure, Secondary
Recombinant Proteins - chemistry
Recombinant Proteins - isolation & purification
Recombinant Proteins - pharmacology
Serine
Spectrometry, Fluorescence
Tissue Plasminogen Activator - antagonists & inhibitors
Urokinase-Type Plasminogen Activator - antagonists & inhibitors
title A fluorescent probe study of plasminogen activator inhibitor-1. Evidence for reactive center loop insertion and its role in the inhibitory mechanism
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T07%3A09%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20fluorescent%20probe%20study%20of%20plasminogen%20activator%20inhibitor-1.%20Evidence%20for%20reactive%20center%20loop%20insertion%20and%20its%20role%20in%20the%20inhibitory%20mechanism&rft.jtitle=The%20Journal%20of%20biological%20chemistry&rft.au=Shore,%20J%20D&rft.date=1995-03-10&rft.volume=270&rft.issue=10&rft.spage=5395&rft.pages=5395-&rft.issn=0021-9258&rft_id=info:doi/10.1074/jbc.270.10.5395&rft_dat=%3Cpubmed%3E7890653%3C/pubmed%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p206t-3bcb6c5bf4681a15113381de474e68ef9b32b008866684f07ff9bbefd9e6d9b43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/7890653&rfr_iscdi=true